Cargando…
The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies
Over time, the antigenic evolution of emerging variants of SARS-CoV-2 has demanded the development of potential protective vaccines. Administration of additional doses of current vaccines based on the WT spike protein may boost immunity, but their effectiveness has dwindled for patients with more re...
Autores principales: | Shafaati, Maryam, Bagherzadeh, Kowsar, Lotfinia, Majid, Karimi, Hesam, Teimoori, Ali, Razazian, Mehdi, Meidaninikjeh, Sepideh, Hosseini, Hamed, Jamshidi, Hamid Reza, Jalili, Hasan, Abdoli, Asghar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968494/ https://www.ncbi.nlm.nih.gov/pubmed/36873499 http://dx.doi.org/10.1016/j.heliyon.2023.e14108 |
Ejemplares similares
-
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern
por: Salehi, Mohammadreza, et al.
Publicado: (2022) -
Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial
por: Mohraz, Minoo, et al.
Publicado: (2023) -
Bivs, Space and ‘In’
por: Mac Cumhaill, Clare
Publicado: (2020) -
Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial
Publicado: (2023) -
Characterization of BIV Env core: Implication for mechanism of BIV-mediated cell fusion
por: Li, Shu, et al.
Publicado: (2005)